Home / Drug shortages / Hydromorphone Hydrochloride Injection

Hydromorphone Hydrochloride Injection — FDA Drug Shortage

Current — Hospira, Inc., a Pfizer Company

The FDA lists a drug shortage record for Hydromorphone Hydrochloride Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 10/31/2017.

Shortage Details

Status
Current
Company
Hospira, Inc., a Pfizer Company
Package NDC
0409-1312-30
Dosage Form
Injection
Presentation
Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30)
Initial Posting
10/31/2017
Revised Date

FDA data resources